Denmark, Finland, and Sweden this week said they are limiting use of Moderna Inc.'s (MRNA) COVID-19 shot over concerns about rare cases of myocarditis and pericarditis in younger people who have received the vaccine. Each country has a different policy; for example, Finland is no longer offering the Moderna shot to men who are younger than 30, according to media reports. Shares of Moderna Inc. (MRNA) were down 9.1% in premarket trading on Thursday. The stock is up 189.5% this year, while the S&P 500 is up 15.7%.
(END) Dow Jones Newswires
October 07, 2021 10:20 ET (14:20 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.